Anthem partners with Samsung, American Well on telehealth offering

Fierce Healthcare | July 23, 2018

Anthem members will be able to access medical advice through a mobile telehealth app on their Samsung phone thanks to a new three-way partnership with the technology giant and American Well. The collaboration will provide access to American Well physicians through an updated Samsung Health app that now offers access to LiveHealth Online, according to Monday’s announcement. The new partnership streamlines several existing contracts between the three companies. Samsung launched its Health Experts service last year, embedding American Well’s platform into its Samsung Health application. The addition of Anthem, which operates Blue Cross Blue Shield plans in 14 states, opens the service up to 74 million members.

Spotlight

Need application specific connectors for your medical device? Check out this video to see how ITT Cannon has the reach, expertise, experience and flexibility to help you bring your innovation to the medical market.

Spotlight

Need application specific connectors for your medical device? Check out this video to see how ITT Cannon has the reach, expertise, experience and flexibility to help you bring your innovation to the medical market.

Related News

HEALTH TECHNOLOGY

ZS and Abacus Insights Partner to Bring Innovative Data and Analytics to Health Plans

ZS and Abacus Insights | November 30, 2022

As ZS continues to help health plans evolve and transform, the firm announced an investment in and partnership with Abacus Insights, a healthcare technology leader with a groundbreaking offering in data usability that rapidly accelerates the achievement of key health plan goals including efficiency, equity, health services and member outcomes. “At ZS, we believe the future of healthcare is connected, with providers, health plans, pharma companies and other stakeholders working together. Usable data from Abacus Insights is a key enabler and connecter, and we take seriously our role in helping health plans innovate and excel. Partnerships like this one between ZS and Abacus Insights will be increasingly important in a connected health ecosystem.” ZS CEO Pratap Khedkar Abacus Insights offers the capability to consolidate and clean billions of pieces of structured and unstructured data from payers, providers, labs, digital apps and many more sources, providing end users with complete, current and accurate data sets that drive both operational and analytical uses. Through this partnership, health plans working with ZS gain access to usable data and a full suite of analytics and digital tools, unlocking insights from sales to operations to health outcomes and accelerating a path to decisions and actions. “Abacus Insights is proud to have the support of ZS both as an investor and partner. ZS recognizes that data usability is a game-changer in creating and scaling big performance advances for health plans,” said Minal Patel, Abacus Insights CEO. “Our companies share a common purpose to improve healthcare. Our combined health plan-specific expertise will accelerate our ability to help clients achieve their key transformational goals of better serving their members and leading healthcare change.” Usable data from Abacus Insights is already powering better quality reporting, more accurate risk adjustment and improved value-based contracting, care and payments. ZS Managing Principal Adam Siskind, who leads the firm’s health plan and provider vertical, said the partnership aims to help unlock use cases that health plans can leverage to fully realize the benefits of their analytics transformations. “There is no shortage of health plan challenges to solve, and it seems there is never enough capacity to unravel them. Our partnership with Abacus Insights will help our clients access the solutions they need to not only reach their goals but to do so efficiently and with scale,” Siskind said. “At ZS, we are proud to be the leading firm at the intersection of healthcare and analytics, so it only made sense to join forces with Abacus Insights, a company already recognized as the leader in health plan data usability in the U.S. Our combined capabilities allow us to achieve a new level of impact that all of our health plan clients seek—and all of their members deserve.” About ZS ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading-edge analytics, plus the power of data, science and products to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 12,000 employees in 35 offices worldwide. About Abacus Insights Abacus Insights is a healthcare technology leader with the only data transformation platform and solutions built specifically for health plans. Focused on data usability, Abacus Insights gives payers a new level of control and flexibility with their data by developing accurate, timely, and robust ecosystems that can support analytics and operational use cases. Managing data for 21 million members, Abacus Insights partners with payers to deliver scalable solutions that drive strategic initiatives, control costs, and improve member lives and experiences.

Read More

DIGITAL HEALTHCARE, MEDICAL DEVICES

Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite

SofWave Medical, Ltd. | December 20, 2022

Sofwave Medical Ltd an emerging leader in energy-based non-invasive, aesthetic medical devices announced the U.S. Food and Drug Administration’s clearance of Sofwave’s SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite. Dr. Shimon Eckhouse, Chairman & Co-Founder commented on the occasion, “We are pleased to receive FDA clearance to use the Company's proprietary SUPERB™ technology to improve the appearance of cellulite in the short term. Non-invasive treatment of cellulite is one of the most desired body treatments in medical aesthetics because of the high prevalence of cellulite in women of all ages and the lack of effective and safe solutions with no patient down-time. Sofwave has shown once again that its investment in the development of the SUPERB™ technology to treat highly prevalent aesthetic indications bears significant fruit and will support the continued rapid growth of the Company. Our disruptive SUPERB™ technology was designed to be efficient and easy to use, and the Company invests and plans to continue investing in bringing innovative solutions to the growing aesthetic technology market generating great ROI to our physician customers.” In the clinical trials submitted to the FDA as part of the 510(k) application in support of the cellulite FDA clearance, the Company conducted a multi-site clinical study that evaluated the safety and effectiveness of the device for the non-invasive dermatological aesthetic improvement in cellulite appearance. A total of 68 women were treated at 4 sites in the United States. Eligible patients received 2 treatments using SUPERB™ technology on one side (right or left) of the lateral / posterior upper thigh or buttocks. Serial clinical photographs were collected under standardized conditions before treatment and at the 3-month follow-up visits. Photographs were assessed by blinded independent reviewers to identify pre-treatment images when compared to post treatment images and to grade the pre-treatment and post-treatment images using the Cellulite Severity Scale (CSS). Improvement was also evaluated using the Global Aesthetic Improvement Scale (GAIS) and Laxity Scale (LS). Safety assessments included evaluation of adverse events via physician examination during and after the treatment. Post-study, the blinded reviewers correctly identified the post treatment images for 89% of the subjects. No serious or unanticipated adverse event was reported during the study. “The FDA's clearance of SUPERB™ for use in cellulite could not have come at a timelier moment. Our dedicated U.S. direct sales force is positioned to expand our growing presence and market share of the aesthetic medical device market in the U.S. In addition, our recent regulatory clearance in Brazil further extends our global footprint, letting us immediately launch sales in this important and sizeable market. Furthermore, our partnership in China with HTDK, one of Asia's strongest healthcare solutions providers, covers our expansion in that territory. Our focused commitment across these major markets, will go a long way towards further accelerating global sales and brand-recognition of our devices in the upcoming new year.” Lou Scafuri, Sofwave's CEO In 2021, the FDA cleared additional indications for SUPERB™ technology, for lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue; which can also affect the appearance of lax tissue in the submental neck regions. In addition, the Sofwave SUPERB™ technology is also cleared by the U.S. FDA for a non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles. About SUPERB™ Sofwave’s state-of-the-art SUPERB™ Technology addresses the growing demand for non-invasive treatments that deliver noticeable results in non-invasive treatment of highly desired aesthetic indications. The device’s cooled transducers are directly coupled to the epidermis, creating a unique 3D array of volumetric thermal zones that deliver parallel energy simultaneously, heating precisely at the right depth in the mid-dermis. A single Sofwave treatment reduces facial wrinkles in a fast 30 to 45 minute non-invasive treatment with no interruption to a patient’s daily routine or post-treatment discomfort. About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue and the short term improvement in the appearance of cellulite providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.

Read More

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

eSight Introduces New Assistive Device for Legally Blind People

eSight | January 04, 2023

eSight, a leading vision-enhancement platform, announced the launch of eSight Go, its most recent innovation in assistive technology. With its enhanced visual clarity, lightweight design, and expansive field of view, the wearable gadget establishes a new benchmark for enhanced vision technology, allowing people with central vision loss to gain independence in their daily lives. The company said that it has greatly improved the capacity and design of its digital eyewear. It is not only to help people who are blind see better but also to make their lives smoother and more manageable. Through a flexible, wearable design that does not restrict the wearer's peripheral vision, eSight devices improve vision for thousands of people with over 20 eye conditions. In addition, the mobility-preserving structure of eSight Go allows for use anywhere, at any time. eSight Go uses the best-matched camera and lens to project a superior image onto two high-resolution screens for binocular vision. Its users can alter the internal OLED's color and contrast. A broader field of view (45 degrees) amplifies vision for unrivaled mobility. Additionally, its new features include better navigation and image stabilization software, a 12-megapixel camera, 4K capabilities, and full HD OLED panels that deliver the sharpest picture with 170 grams comfortably distributed around the neck. eSight Go will debut at CES 2023 and launch in Q4 2023. The device will be showcased at the Gentex booth (#6341) from January 5-8, 2023. About eSight eSight is an innovative vision platform that promises to help people who are blind see new opportunities. It helps patients with macular degeneration, diabetic retinopathy, and 50 other vision-loss conditions. The first eSight Eyewear prototype was released in 2013. Time Magazine named eSight 3 one of 'The 25 Best Inventions of 2017' while Buzzfeed named it one of the '6 Inventions Changing British Lives in 2017'.

Read More